The investigation shows women and White patients are most likely to be affected.
Researchers evaluated the diagnostic accuracy of ultrasound examination in patients with suspected giant cell arteritis.
Researchers aimed to provide deeper insight into the predictors of mortality and survival in patients with VEXAS syndrome.
Researchers evaluated the pharmacologic response of rituximab dosing for maintenance therapy in patients with ANCA-associated vasculitis.
Members of the Hughes-Stovin syndrome (HSS) International Study Group developed a reference “atlas” of images to describe the characteristic features of HSS and inform diagnosis and management of HSS-related pulmonary vasculitis.
The approval was based on data from the phase 3 ADVOCATE trial, which evaluated Tavneos in 330 adults with newly diagnosed or relapsed ANCA-associated vasculitis.
Authors reported the case of an 83-year-old woman with a history of asthma and rheumatoid arthritis who presented with left abdominal pain.
Recurrence dropped dramatically from 115 per 100 patients each year to before the start of SB5 to 3 relapses per 100 patients each year with the treatment.
Using a large nationwide electronic database, researchers assessed the association between giant cell arteritis and risk for malignancies.
The American College of Rheumatology and Vasculitis Foundation released evidence-based recommendations for the management of giant cell arteritis and Takayasu arteritis.